{"owner_org": "6952e207-496b-42be-a728-1dd0f07c162d", "maintainer": null, "relationships_as_object": [], "data_dict": "{\"license_title\": \"\", \"maintainer\": null, \"relationships_as_object\": [], \"private\": false, \"maintainer_email\": null, \"num_tags\": 0, \"id\": \"69828eb3-7ebd-443d-9e8b-4aaf06883bab\", \"metadata_created\": \"2013-08-30T16:53:09.613058\", \"metadata_modified\": \"2013-11-08T08:16:34.249563\", \"author\": null, \"author_email\": null, \"state\": \"active\", \"version\": null, \"license_id\": \"\", \"type\": \"dataset\", \"resources\": [], \"num_resources\": 0, \"tags\": [], \"tracking_summary\": {\"total\": 0, \"recent\": 0}, \"groups\": [], \"organization\": {\"description\": \"The Medicines and Healthcare Products Regulatory Agency (MHRA) protects and promotes public health and patient safety by ensuring that medicines, healthcare products and medical equipment meet appropriate standards of safety, quality, performance and effectiveness and are used safely. The MHRA was formed from a merger of the Medicines Control Agency and the Medical Devices Agency on 1 April 2003.\\r\\n\\r\\nMHRA is an executive agency of the Department of Health\\r\\n\\r\\nhttp://www.mhra.gov.uk\\r\\n\", \"title\": \"Medicines and Healthcare products Regulatory Agency\", \"created\": \"2012-06-27T14:52:10.525619\", \"approval_status\": \"pending\", \"revision_timestamp\": \"2013-11-08T08:16:34.249563\", \"is_organization\": true, \"state\": \"active\", \"image_url\": \"\", \"revision_id\": \"6b4acea9-36f2-4c44-940a-c2699c105f10\", \"type\": \"organization\", \"id\": \"6952e207-496b-42be-a728-1dd0f07c162d\", \"name\": \"medicines-and-healthcare-products-regulatory-agency\"}, \"relationships_as_subject\": [], \"revision_timestamp\": \"2013-08-30T16:53:09.613058\", \"name\": \"serious-adverse-blood-reactions-and-events-sabre\", \"isopen\": false, \"url\": null, \"notes\": \"adverse reactions and events involving blood products.  Continuous collection. Safety reports  concerning blood - collection, analysis and response\", \"owner_org\": \"6952e207-496b-42be-a728-1dd0f07c162d\", \"extras\": [{\"state\": \"active\", \"value\": \"\", \"revision_timestamp\": \"2013-08-30T16:53:09.613058\", \"package_id\": \"69828eb3-7ebd-443d-9e8b-4aaf06883bab\", \"key\": \"publish-date\", \"revision_id\": \"a4584c17-65dd-4abb-b0ba-3edb7b43585e\", \"id\": \"686f5839-7340-4b35-b263-a4be94b4cdce\"}, {\"state\": \"active\", \"value\": \"data used in MHRA reports\", \"revision_timestamp\": \"2013-08-30T16:53:09.613058\", \"package_id\": \"69828eb3-7ebd-443d-9e8b-4aaf06883bab\", \"key\": \"release-notes\", \"revision_id\": \"a4584c17-65dd-4abb-b0ba-3edb7b43585e\", \"id\": \"8c17719c-c026-4a65-b483-85f9bc2f19ab\"}, {\"state\": \"active\", \"value\": \"true\", \"revision_timestamp\": \"2013-08-30T16:53:09.613058\", \"package_id\": \"69828eb3-7ebd-443d-9e8b-4aaf06883bab\", \"key\": \"unpublished\", \"revision_id\": \"a4584c17-65dd-4abb-b0ba-3edb7b43585e\", \"id\": \"7274a49a-9de9-44fa-97d4-f517aa6de02d\"}], \"title\": \"Serious Adverse Blood Reactions and Events (SABRE)\", \"revision_id\": \"a4584c17-65dd-4abb-b0ba-3edb7b43585e\"}", "private": false, "maintainer_email": null, "num_tags": 0, "id": "69828eb3-7ebd-443d-9e8b-4aaf06883bab", "metadata_created": "2013-08-30T16:53:09.613058", "metadata_modified": "2013-11-08T08:16:34.249563", "author": null, "author_email": null, "state": "active", "version": null, "license_id": "", "type": "dataset", "unpublished": "true", "resources": [], "num_resources": 0, "tags": [], "title": "Serious Adverse Blood Reactions and Events (SABRE)", "release-notes": "data used in MHRA reports", "publish-date": "", "groups": [], "relationships_as_subject": [], "revision_timestamp": "2013-08-30T16:53:09.613058", "name": "serious-adverse-blood-reactions-and-events-sabre", "isopen": false, "url": null, "notes": "adverse reactions and events involving blood products.  Continuous collection. Safety reports  concerning blood - collection, analysis and response", "license_title": "", "tracking_summary": {"total": 0, "recent": 0}, "extras": [{"state": "active", "value": "", "revision_timestamp": "2013-08-30T16:53:09.613058", "package_id": "69828eb3-7ebd-443d-9e8b-4aaf06883bab", "key": "publish-date", "revision_id": "a4584c17-65dd-4abb-b0ba-3edb7b43585e", "id": "686f5839-7340-4b35-b263-a4be94b4cdce"}, {"state": "active", "value": "data used in MHRA reports", "revision_timestamp": "2013-08-30T16:53:09.613058", "package_id": "69828eb3-7ebd-443d-9e8b-4aaf06883bab", "key": "release-notes", "revision_id": "a4584c17-65dd-4abb-b0ba-3edb7b43585e", "id": "8c17719c-c026-4a65-b483-85f9bc2f19ab"}, {"state": "active", "value": "true", "revision_timestamp": "2013-08-30T16:53:09.613058", "package_id": "69828eb3-7ebd-443d-9e8b-4aaf06883bab", "key": "unpublished", "revision_id": "a4584c17-65dd-4abb-b0ba-3edb7b43585e", "id": "7274a49a-9de9-44fa-97d4-f517aa6de02d"}], "organization": {"description": "The Medicines and Healthcare Products Regulatory Agency (MHRA) protects and promotes public health and patient safety by ensuring that medicines, healthcare products and medical equipment meet appropriate standards of safety, quality, performance and effectiveness and are used safely. The MHRA was formed from a merger of the Medicines Control Agency and the Medical Devices Agency on 1 April 2003.\r\n\r\nMHRA is an executive agency of the Department of Health\r\n\r\nhttp://www.mhra.gov.uk\r\n", "created": "2012-06-27T14:52:10.525619", "title": "Medicines and Healthcare products Regulatory Agency", "name": "medicines-and-healthcare-products-regulatory-agency", "revision_timestamp": "2013-11-08T08:16:34.249563", "is_organization": true, "state": "active", "image_url": "", "revision_id": "6b4acea9-36f2-4c44-940a-c2699c105f10", "type": "organization", "id": "6952e207-496b-42be-a728-1dd0f07c162d", "approval_status": "pending"}, "revision_id": "a4584c17-65dd-4abb-b0ba-3edb7b43585e"}